Search - tctmd.com

Displaying 41 - 60 of 66

Sort: Relevancy | Date

News Daily News

TAVR Bleeds Stand Apart From PCI-Related Events

Caitlin E. Cox

August 06, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for July 2019

Shelley Wood

July 31, 2019

News Daily News

RAS Inhibition After TAVR Gains More Support, but RCT Still Needed

Todd Neale

July 29, 2019

News Daily News

Most Supplements and Diets Don’t Lower CVD or Mortality Risks

Michael O'Riordan

July 09, 2019

News Daily News

Field in Flux: What’s the Best Antithrombotic Strategy for A-fib Patients Undergoing PCI?

Michael O'Riordan

July 03, 2019

News Daily News

Which ASCVD Patients Will Benefit Most From Rivaroxaban Plus Aspirin? Some Clues

Todd Neale

June 26, 2019

Presentation TVT 2019

Echocardiographic Surveillance and Antithrombotic Therapy After LAA Closure

Presenter: Jacqueline Saw

June 13, 2019

News Daily News

Potential Warning Signs Seen for NOAC Use After TAVR

Todd Neale

June 12, 2019

News Conference News EuroPCR 2019

Amplatzer Amulet LAA Closure Device Reduces Stroke Through 2 Years: Global Registry

Caitlin E. Cox

May 31, 2019

News Conference News EuroPCR 2019

New Clarity on Patients at High Risk for Bleeding After PCI

Michael O'Riordan

May 28, 2019

News Conference News SCAI 2019

Antithrombotic Use, Risk Perception, Varies Widely for PCI Patients With A-fib

Yael L. Maxwell

May 24, 2019

News Conference News EuroPCR 2019

TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement

Shelley Wood

May 23, 2019

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Daily News

Device-Related Thrombus and LAA Closure: Rare but Dangerous

Yael L. Maxwell

May 09, 2019

News Features

Twitter Takes on the Times of India, but the Question Persists: Is Foregoing a Stent an Option?

Shelley Wood

April 30, 2019

News Daily News

Continuing Anticoagulation During TAVR: New Data Offer a Glimpse of What Works

Shelley Wood

April 16, 2019

Presentation CIT 2019

Dual Pathway Antithrombotic Inhibition for Stable Atherosclerosis

Presenter: Davide Capodanno

March 28, 2019

Presentation SIF 2019

Fundamentals of Pharmacology: What You Need to Know as an Interventionalist

Presenter: Sripal Bangalore

March 27, 2019

News Conference News ACC 2019

REDUCE-IT Subanalysis: Icosapent Ethyl Reduces Total and Recurrent CV Events

Yael L. Maxwell

March 22, 2019

News Daily News

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

Shelley Wood

February 19, 2019

Advertisement

TAVR Bleeds Stand Apart From PCI-Related Events

TCTMD’s Top 10 Most Popular Stories for July 2019

RAS Inhibition After TAVR Gains More Support, but RCT Still Needed

Most Supplements and Diets Don’t Lower CVD or Mortality Risks

Field in Flux: What’s the Best Antithrombotic Strategy for A-fib Patients Undergoing PCI?

Which ASCVD Patients Will Benefit Most From Rivaroxaban Plus Aspirin? Some Clues

Echocardiographic Surveillance and Antithrombotic Therapy After LAA Closure

Potential Warning Signs Seen for NOAC Use After TAVR

Amplatzer Amulet LAA Closure Device Reduces Stroke Through 2 Years: Global Registry

New Clarity on Patients at High Risk for Bleeding After PCI

Antithrombotic Use, Risk Perception, Varies Widely for PCI Patients With A-fib

TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Device-Related Thrombus and LAA Closure: Rare but Dangerous

Twitter Takes on the Times of India, but the Question Persists: Is Foregoing a Stent an Option?

Continuing Anticoagulation During TAVR: New Data Offer a Glimpse of What Works

Dual Pathway Antithrombotic Inhibition for Stable Atherosclerosis

Fundamentals of Pharmacology: What You Need to Know as an Interventionalist

REDUCE-IT Subanalysis: Icosapent Ethyl Reduces Total and Recurrent CV Events

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content